DAP1 high expression increases risk of lymph node metastases in squamous cell carcinoma of the oral cavity

• Autor(a) principal: Santos, Marcelo dos
• Data de Publicação: 2015
• Outros Autores: Maia, L. L., Silva, C. V. M., Peterle, G. T., Mercante, A. M. C., Nunes, F. D., Carvalho, M. B., Tajara, E. H., Louro, I. D., Silva-Conforti, A. M. A.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFRN
• DOI: 10.4238/2015.September.8.13
• Texto Completo: https://repositorio.ufrn.br/handle/123456789/31436
• topic: DAP1 expression; Lymph node; Prognostic marker; Oral cancer

Death-associated protein 1 (DAP1) is a member of the DAP family. Its expression is associated with cell growth and normal death of the neoplastic cells, regulated by the mammalian target of the rapamycin protein. Activated DAP1 negatively regulates autophagy, which has been associated with the development and progression of several diseases, such as cancer, and with prognosis and survival of diverse tumor types. Therefore, in this study we analyzed DAP1 expression in 54 oral squamous cell carcinoma tumor samples and in 20 non-tumoral margins by immunohistochemistry. The results showed that DAP1 is more frequently expressed in tumor tissues compared with marginal non-tumoral cells. Additionally, high DAP1 expression is associated with a 4-fold increase in the risk of lymph node metastases. Our results suggest that the DAP1 protein can be used as a potential marker of lymph node metastases predisposition, helping define the best therapy for each patient to minimize risk of developing metastases